Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 AUD | 0.00% | 0.00% | -0.60% |
02-28 | NobleOak Life Shares Add 7% Despite 55% Plunge in Fiscal H1 Profit | MT |
02-28 | Transcript : NobleOak Life Limited, H1 2024 Earnings Call, Feb 28, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.18 for the current year.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company sustains low margins.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.60% | 92.95M | - | ||
+3.05% | 95.15B | B | ||
+1.78% | 94.71B | B- | ||
-20.65% | 77.24B | B+ | ||
+18.68% | 74.93B | D+ | ||
+6.69% | 30.04B | B | ||
+18.06% | 27.87B | B | ||
+4.32% | 26.97B | A | ||
-1.21% | 16.99B | C+ | ||
-9.10% | 15.16B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NOL Stock
- Ratings NobleOak Life Limited